Associations Between Time to Reduction and Complications in Patients With Dislocated Total Hip Arthroplasty
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNordsjaellands Hospital
About this trial
The aim of the study is to investigate the impact of time to closed reduction on both patient related and organizational factors. These include, length of stay, hospitalization, admission to intensive care unit, rehospitalizations, delirium, all-cause mortality, infection requiring hospital contact, and cardiovascular complications. It is also intended to investigate whether different anaesthetic strategies and airway management are associated with different complication rates.
It is hypothesized that longer waiting time until reduction increase the postoperative length of stay, readmissions, and risk of complications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18 years or older
Presented to the emergency department with a dislocated total hip arthroplasty.
Undergo closed reduction of the dislocated total hip arthroplasty in the operating theatre, with the involvement of the Department of Anesthesiology.
Disqualifiers
Were primarily booked for open surgical reduction.
Did not have a complete case log (i.e. time of admission; referral to the operation theatre; anesthesia induction; discharge, etc.) and we were unable to recreate the log using simple code rules.
Trial population
The cohort contains all adults presenting with a dislocated THA, who underwent closed reduction in an operating theatre with anesthesiology being involved, in public hospitals in the Capital and Zealand Regions of Denmark. The study population is extracted from a dataset retrieved from the Electronic Health Record (EHR) system 'Sundhedsplatformen' (Epic Systems Corporation, WI, USA) from 1 January 2017 to 31 December 2024, including granular data from approximately 1.1 million anesthetic procedures
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Time in minutes from admission to closed reduction
Other interventionTime in minutes from admission to closed reduction measured as: From arriving time in the emergency department until the start of surgery in the operating theater.
Treatment groups
3,700 Participants
are divided into 1 treatment groupGroup A: patients underwent closed reduction of dislocated THA1 intervention
Trial outcomes
Primary outcomes
1
Post procedure length of stay
Post procedure length of stay from closed reduction until discharge from the hospital (hours)
Time frame
30 days after the closed reductionSecondary outcomes
1
All-cause mortality
90 days all-cause mortality (Y/N)
Time frame
90 days after closed reduction2
Admissions to Intensive care unit
Admissions to the intensive care unit within 30 days after the closed reduction.
Time frame
30 days after the closed reduction3
Readmission
Readmission within 30 days after discharge
Time frame
30 days after discharge4
Delirium during admission
Defined as diagnose of delirium (F05.x, obtained from the diagnosis codes from the given admission) or the non-planned administration of haloperidol, olanzapine, risperidone, or quetiapine (as a surrogate for new onset delirium)
Time frame
From admission to discharge up to 30 days after closed reductionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: